Lifeboat Foundation

If most robots still need remote human operators to be safe and effective, why should we welcome them into our homes?

Monitoring electrical signals in biological systems helps scientists understand how cells communicate, which can aid in the diagnosis and treatment of conditions like arrhythmia and Alzheimer’s.

But devices that record electrical signals in cell cultures and other liquid environments often use wires to connect each electrode on the device to its respective amplifier. Because only so many wires can be connected to the device, this restricts the number of recording sites, limiting the information that can be collected from cells.

MIT researchers have now developed a biosensing technique that eliminates the need for wires. Instead, tiny, wireless antennas use light to detect minute electrical signals.

Astrophycists from UCLan have determined that flat planets rather than spherical are the result of protoplanetary formation with the disk-instability theory.

While word-finding failures can be taken as evidence of memory problems, they may not be harbingers of befuddlement after all.

A glowing galaxy not far from the Milky Way has been harboring a strange, puzzling secret at its core.

In the center of NGC 5,084, some 80 million light-years away, the supermassive black hole around which the whole galaxy revolves has been discovered tipped over on its side, with its rotational axis parallel to the galactic plane.

Continue reading “Supermassive Black Hole Found Tipped Onto Its Side by Mystery Event” »

Hallucinations, a bane of popular A.I. programs, turn out to be a boon for venturesome scientists eager to push back the frontiers of human knowledge.

In the simulation hypothesis, some scientists believe we could outsmart the simulator—even in the unlikely case we’re just glitches in the code.

Leveraging the success of this new program, just about two years from its launch DeepMind’s AI spinout Isomorphic announced two drug discovery deals, worth $3 billion each, with Eli Lilly and Novartis.

Earlier this year, microprocessor giant NVIDIA also dove head first into AI for drug discovery, making big investments and deals with leaders like Recursion Pharmaceuticals and Genentech.

AI in drug discovery seems to be having a moment.

Is booming, with retail sales set to rise 39% by 2027. A new report from the Forum highlights urban delivery challenges and solutions.